
Robert B. Mondesi
Supervisory Patent Examiner (ID: 14909, Phone: (571)272-0956 , Office: P/1652 )
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1653, 1652, 1645 |
| Total Applications | 414 |
| Issued Applications | 168 |
| Pending Applications | 94 |
| Abandoned Applications | 160 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17790374
[patent_doc_number] => 20220249465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => UNIT DOSAGE FORM FOR TRANSMUCOSAL DRUG DELIVERY OF AN ACTIVE PHARMACEUTICAL INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 17/610965
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10364
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17610965
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/610965 | UNIT DOSAGE FORM FOR TRANSMUCOSAL DRUG DELIVERY OF AN ACTIVE PHARMACEUTICAL INGREDIENT | May 28, 2020 | Pending |
Array
(
[id] => 17774864
[patent_doc_number] => 20220241213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => DELAYED AND SUSTAINED DELIVERY OF ANTICANCER DRUGS
[patent_app_type] => utility
[patent_app_number] => 17/618662
[patent_app_country] => US
[patent_app_date] => 2020-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6828
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17618662
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/618662 | DELAYED AND SUSTAINED DELIVERY OF ANTICANCER DRUGS | May 24, 2020 | Abandoned |
Array
(
[id] => 17759851
[patent_doc_number] => 20220233463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => LOCAL ANESTHETIC COMPRISING A TRP CHANNEL MODULATOR
[patent_app_type] => utility
[patent_app_number] => 17/611583
[patent_app_country] => US
[patent_app_date] => 2020-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5766
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17611583
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/611583 | LOCAL ANESTHETIC COMPRISING A TRP CHANNEL MODULATOR | May 13, 2020 | Abandoned |
Array
(
[id] => 17774856
[patent_doc_number] => 20220241205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => Improved Lyophilized Formulations Involving Hyaluronic Acid and Plasmatic Proteins, and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/610254
[patent_app_country] => US
[patent_app_date] => 2020-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21138
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17610254
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/610254 | Improved Lyophilized Formulations Involving Hyaluronic Acid and Plasmatic Proteins, and Uses Thereof | May 12, 2020 | Abandoned |
Array
(
[id] => 17670814
[patent_doc_number] => 20220183981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => SPRAY-DRIED FORMULATION OF A PYRIDAZINONE TRPC5 INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/603299
[patent_app_country] => US
[patent_app_date] => 2020-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21894
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -70
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17603299
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/603299 | SPRAY-DRIED FORMULATION OF A PYRIDAZINONE TRPC5 INHIBITOR | Apr 9, 2020 | Pending |
Array
(
[id] => 17625590
[patent_doc_number] => 20220160605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => OIL-IN-WATER TYPE EMULSIFICATION COMPOSITION CONTAINING UV WAVELENGTH CONVERSION SUBSTANCE
[patent_app_type] => utility
[patent_app_number] => 17/601317
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601317
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/601317 | OIL-IN-WATER TYPE EMULSIFICATION COMPOSITION CONTAINING UV WAVELENGTH CONVERSION SUBSTANCE | Apr 2, 2020 | Pending |
Array
(
[id] => 17655159
[patent_doc_number] => 20220175624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => POWDER COSMETIC CONTAINING ULTRAVIOLET WAVELENGTH-CONVERTING SUBSTANCE, AND METHOD FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 17/601262
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11540
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601262
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/601262 | POWDER COSMETIC CONTAINING ULTRAVIOLET WAVELENGTH-CONVERTING SUBSTANCE, AND METHOD FOR PRODUCING SAME | Apr 2, 2020 | Abandoned |
Array
(
[id] => 17655172
[patent_doc_number] => 20220175637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => COMPOSITION COTAINING ULTRAVIOLET WAVELENGTH-CONVERTING SUBSTANCE AND HYDROPHOBIZED SILICA AND/OR HYDROPHOBIZED STARCH
[patent_app_type] => utility
[patent_app_number] => 17/601333
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11502
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601333
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/601333 | COMPOSITION COTAINING ULTRAVIOLET WAVELENGTH-CONVERTING SUBSTANCE AND HYDROPHOBIZED SILICA AND/OR HYDROPHOBIZED STARCH | Apr 2, 2020 | Pending |
Array
(
[id] => 17671047
[patent_doc_number] => 20220184214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => MULTICOMPONENT THERMOPLASTIC PRODUCT
[patent_app_type] => utility
[patent_app_number] => 17/598344
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7149
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17598344
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/598344 | MULTICOMPONENT THERMOPLASTIC PRODUCT | Mar 26, 2020 | Abandoned |
Array
(
[id] => 17655167
[patent_doc_number] => 20220175632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => OIL-IN-WATER EMULSION COSMETIC
[patent_app_type] => utility
[patent_app_number] => 17/599444
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5569
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17599444
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/599444 | OIL-IN-WATER EMULSION COSMETIC | Mar 26, 2020 | Abandoned |
Array
(
[id] => 17625597
[patent_doc_number] => 20220160612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => COSMETIC USE OF AMYLOSE-RICH STARCH AS FILM-FORMING AGENT WITH BARRIER AND FIXATIVE EFFECTS
[patent_app_type] => utility
[patent_app_number] => 17/593932
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7698
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17593932
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/593932 | COSMETIC USE OF AMYLOSE-RICH STARCH AS FILM-FORMING AGENT WITH BARRIER AND FIXATIVE EFFECTS | Mar 26, 2020 | Abandoned |
Array
(
[id] => 17670828
[patent_doc_number] => 20220183995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => SLEEP AID TRANSDERMAL PATCH AND ITS PROCESS OF PREPARATION
[patent_app_type] => utility
[patent_app_number] => 17/442523
[patent_app_country] => US
[patent_app_date] => 2020-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5168
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17442523
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/442523 | SLEEP AID TRANSDERMAL PATCH AND ITS PROCESS OF PREPARATION | Mar 25, 2020 | Abandoned |
Array
(
[id] => 17593415
[patent_doc_number] => 20220142988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => Materials and Methods for Enhanced Treatment and Prevention of Biofilms
[patent_app_type] => utility
[patent_app_number] => 17/430021
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430021
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/430021 | Materials and Methods for Enhanced Treatment and Prevention of Biofilms | Mar 12, 2020 | Abandoned |
Array
(
[id] => 17671104
[patent_doc_number] => 20220184271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => COATING-SECURING AGENT
[patent_app_type] => utility
[patent_app_number] => 17/439938
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6279
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17439938
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/439938 | COATING-SECURING AGENT | Mar 12, 2020 | Pending |
Array
(
[id] => 17640730
[patent_doc_number] => 20220168468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => CELL ENCAPSULATION DEVICES AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/437998
[patent_app_country] => US
[patent_app_date] => 2020-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10165
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17437998
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/437998 | CELL ENCAPSULATION DEVICES AND METHODS OF USING SAME | Mar 10, 2020 | Abandoned |
Array
(
[id] => 20239513
[patent_doc_number] => 12419816
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-23
[patent_title] => Particulate amorphous mesoporous magnesium carbonate material
[patent_app_type] => utility
[patent_app_number] => 17/433039
[patent_app_country] => US
[patent_app_date] => 2020-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 5623
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17433039
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/433039 | Particulate amorphous mesoporous magnesium carbonate material | Feb 24, 2020 | Issued |
Array
(
[id] => 17640479
[patent_doc_number] => 20220168217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => DRUG DELIVERY SILICONE COMPOSITION TO IMPROVE ACTIVE INGREDIENT ELUTION
[patent_app_type] => utility
[patent_app_number] => 17/432391
[patent_app_country] => US
[patent_app_date] => 2020-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4387
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 301
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17432391
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/432391 | DRUG DELIVERY SILICONE COMPOSITION TO IMPROVE ACTIVE INGREDIENT ELUTION | Feb 19, 2020 | Pending |
Array
(
[id] => 19839070
[patent_doc_number] => 12251425
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-18
[patent_title] => Sustained-release lipid preformulation and pharmaceutical composition for sustained-release injection in form of lipid solution containing same
[patent_app_type] => utility
[patent_app_number] => 17/310689
[patent_app_country] => US
[patent_app_date] => 2020-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7702
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17310689
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/310689 | Sustained-release lipid preformulation and pharmaceutical composition for sustained-release injection in form of lipid solution containing same | Feb 16, 2020 | Issued |
Array
(
[id] => 17576001
[patent_doc_number] => 20220132856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => PHOTOSENSITIZER AND CHELATING AGENT COMBINATIONS FOR USE AS INSECTICIDES
[patent_app_type] => utility
[patent_app_number] => 17/431306
[patent_app_country] => US
[patent_app_date] => 2020-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11289
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17431306
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/431306 | PHOTOSENSITIZER AND CHELATING AGENT COMBINATIONS FOR USE AS INSECTICIDES | Feb 13, 2020 | Pending |
Array
(
[id] => 17640729
[patent_doc_number] => 20220168467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => MEDICAL DEVICE AND PROCESS OF PREPARING A MEDICAL DEVICE
[patent_app_type] => utility
[patent_app_number] => 17/440017
[patent_app_country] => US
[patent_app_date] => 2020-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6009
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17440017
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/440017 | MEDICAL DEVICE AND PROCESS OF PREPARING A MEDICAL DEVICE | Feb 12, 2020 | Abandoned |